|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Mirza, Mansoor Raza; Lindahl, Gabriel; Mahner, Sven; Redondo, Andres; Fabbro, Michel; Rimel, Bobbie J.; Herrstedt, Jorn; Oza, Amit M.; Canzler, Ulrich; Berek, Jonathan S.; Gonzalez-Martin, Antonio; Follana, Phillipe; Lord, Rosemary; Azodi, Masoud; Estenson, Kasey; Wang, Zebin; Li, Yong; Gupta, Divya; Matulonis, Ursula und Feng, Bin
(2022):
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects.
In: Cancer Research Communications, Bd. 2, Nr. 11: S. 1436-1444
Matulonis, Ursula A.; Walder, Lydia; Nottrup, Trine J.; Bessette, Paul; Mahner, Sven; Gil-Martin, Marta; Kalbacher, Elsa; Ledermann, Jonathan A.; Wenham, Robert M.; Woie, Kathrine; Lau, Susie; Marme, Frederik; Casado Herraez, Antonio; Hardy-Bessard, Anne-Claire; Banerjee, Susana; Lindahl, Gabriel; Benigno, Benedict; Buscema, Joseph; Travers, Karin; Guy, Holly und Mirza, Mansoor R.
(2019):
Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial.
In: Journal of Clinical Oncology, Bd. 37, Nr. 34: S. 3183-3191